Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Popularity leads to shortages Ozempic, which was originally developed to help people with diabetes, has exploded in popularity as a weight loss drug since it came on the market in 2021, leading to worldwide shortages
10.1016/j.bbrc.2019.01.103 Summary Keywords heart failure, cognitive impairment, type 2 diabetes, glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 inhibitors Citation Riemma MA, Mele E, Donniacuo M, Telesca M, Bellocchio G, Castaldo G, Rossi F, De Angelis A, Cappetta D, Urbanek K and Berrino L (2024) Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects
PubMed Su YH, Luo DC, Pang Y
T.ChamT
US$ 20.97
.jpg)
US$ 28.95
US$ 29.50
US$ 20.85
US$ 29.66
US$ 22.64
US$ 22.06
US$ 23.17
US$ 28.64
US$ 21.40
